H. D. Smith reorganizes national operations
SPRINGFIELD, Ill. — Pharmaceutical wholesaler H. D. Smith announced that amid the retirement of one of its executives, the company has reorganized its national operations to meet the regional needs of its customers.
H. D. Smith said that its national operations now will be organized into a West region, which includes California, Illinois, Kentucky and Texas divisions; and East region, which includes Florida, New England and New York Metro divisions. The East and West regions will be overseen by corporate VPs Christian Harrington and Tom Twitty. Both executives will report to H. D. Smith president and COO Chris Smith.
The announcement reflects the retirement of EVP Harvey Tanenbaum, who is leaving the company after 12 years of service. During his tenure, Tanenbaum was the founder of the company’s New York Metro division.
“As H. D. Smith continues to grow, so too does our need for dedicated customer service oversight and operational excellence in every region we serve,” Smith said. “This reorganization enables continued growth and provides new services to our customers — while maintaining focused support for each customer individually. Christian Herrington and Tom Twitty, having come from senior leadership positions within H. D. Smith and having held national positions during their careers, truly understand and are dedicated to this mission.”
Mary Sammons to serve on Magellan’s board
AVON, Conn. — Rite Aid chairman Mary Sammons has been appointed to Magellan Health Services’ board of directors, Magellan said.
The addition of Sammons increases the number of members on Magellan’s board to nine. Sammons began at Rite Aid as president and COO in 1999, becoming CEO in 2003 and chairman in 2007. The current president and CEO is John Standley.
“Mary Sammons is an experienced business leader with significant knowledge of the healthcare industry, and we are pleased that she is joining our board,” Magellan chairman and CEO Rene Lerer said. “The healthcare marketplace is continuing to evolve, and Magellan is positioned to leverage our significant clinical and operational expertise to continue to grow. Mary’s background in successfully leading major companies through transformation will be invaluable as we look to the challenges and opportunities of the future.”
Wolters Kluwer divests pharmacy business
ALPHEN AAN DEN RIJN, Netherlands — Wolters Kluwer will sell its pharma-related business, the market research firm said Wednesday.
The company’s pharmacy business, which includes the brands Source and Adis, includes marketing and publications services, business intelligence products and advanced analytical tools and services to life science professionals.
“The planned divestment of the pharmacy business will focus our health division on taking full advantage of our leading positions in professional information and clinical decision support solutions, one of the fastest growing areas of health, to deliver enhanced value to our stakeholders,” Wolters Kluwer chairman and CEO Nancy McKinstry said.
The company said that Lazard Middle Market and William Blair & Co. were acting as financial advisers and that the deal would close shortly after the end of the year, but it did not name a buyer.